🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 4 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/1973 | 0,0093 USD |
| 31/08/1973 | 0,0078 USD |
| 05/06/1973 | 0,0078 USD |
| 05/03/1973 | 0,0078 USD |
| 05/12/1972 | 0,0078 USD |
| 09/06/1972 | 0,0073 USD |
| 02/03/1972 | 0,0073 USD |
| 06/12/1971 | 0,0073 USD |
| 03/09/1971 | 0,0073 USD |
| 07/06/1971 | 0,0073 USD |
| 02/03/1971 | 0,0073 USD |
| 01/12/1970 | 0,0073 USD |
| 02/09/1970 | 0,0066 USD |
| 02/06/1970 | 0,0066 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/03/1993 | 18,37 | 19,08 | 18,37 | 19,08 | +4,92% | 3,90% | 8.220.093 |
| 09/03/1993 | 18,19 | 18,25 | 17,95 | 18,19 | -0,33% | 1,64% | 4.635.514 |
| 08/03/1993 | 17,89 | 18,25 | 17,65 | 18,25 | +2,00% | 3,33% | 5.692.946 |
| 05/03/1993 | 17,95 | 18,25 | 17,77 | 17,89 | -0,66% | 2,66% | 5.094.118 |
| 04/03/1993 | 18,49 | 18,55 | 17,95 | 18,01 | -2,27% | 3,23% | 4.461.126 |
| 03/03/1993 | 18,55 | 18,55 | 18,31 | 18,43 | -0,64% | 1,29% | 3.933.144 |
| 02/03/1993 | 18,67 | 18,67 | 18,37 | 18,55 | -1,58% | 1,60% | 4.900.867 |
| 01/03/1993 | 18,73 | 19,02 | 18,49 | 18,85 | +2,60% | 2,87% | 5.949.077 |
| 26/02/1993 | 18,49 | 18,49 | 18,25 | 18,37 | +0,33% | 1,29% | 3.678.690 |
| 25/02/1993 | 18,19 | 18,37 | 18,01 | 18,31 | +0,00% | 1,97% | 6.002.315 |
| 24/02/1993 | 17,89 | 18,43 | 17,83 | 18,31 | +1,99% | 3,33% | 8.125.563 |
| 23/02/1993 | 17,53 | 18,19 | 17,18 | 17,95 | +2,73% | 5,78% | 9.666.752 |
| 22/02/1993 | 17,77 | 17,83 | 17,06 | 17,47 | -0,68% | 4,36% | 10.278.574 |
| 19/02/1993 | 18,19 | 18,25 | 17,35 | 17,59 | -2,64% | 4,92% | 9.538.896 |
| 18/02/1993 | 18,19 | 18,25 | 17,65 | 18,07 | +1,00% | 3,28% | 8.871.320 |
| 17/02/1993 | 18,07 | 18,13 | 17,71 | 17,89 | -0,99% | 2,31% | 9.614.981 |
| 16/02/1993 | 18,49 | 18,61 | 17,89 | 18,07 | -6,19% | 3,87% | 11.239.171 |
| 12/02/1993 | 19,44 | 19,50 | 19,08 | 19,26 | -0,92% | 2,15% | 5.256.768 |
| 11/02/1993 | 19,44 | 19,56 | 19,20 | 19,44 | +1,24% | 1,84% | 6.283.389 |
| 10/02/1993 | 18,85 | 19,20 | 18,43 | 19,20 | +2,88% | 4,11% | 7.193.682 |
| 09/02/1993 | 18,43 | 18,79 | 18,25 | 18,67 | +1,62% | 2,91% | 6.062.470 |
| 08/02/1993 | 18,31 | 18,79 | 18,31 | 18,37 | +0,33% | 2,61% | 6.376.451 |
| 05/02/1993 | 18,13 | 18,37 | 17,83 | 18,31 | +0,99% | 2,96% | 7.417.534 |
| 04/02/1993 | 18,85 | 18,85 | 18,01 | 18,13 | -2,88% | 4,43% | 8.388.402 |
| 03/02/1993 | 17,95 | 18,73 | 17,83 | 18,67 | +3,99% | 4,98% | 12.918.277 |
| 02/02/1993 | 18,25 | 18,31 | 17,77 | 17,95 | -3,22% | 2,94% | 16.541.422 |
| 01/02/1993 | 18,91 | 19,02 | 18,49 | 18,55 | -3,72% | 2,84% | 8.968.784 |
| 29/01/1993 | 19,32 | 19,38 | 19,02 | 19,26 | -0,31% | 1,85% | 4.455.258 |
| 28/01/1993 | 19,32 | 19,50 | 19,14 | 19,32 | +0,62% | 1,85% | 5.395.104 |
| 27/01/1993 | 18,91 | 19,26 | 18,85 | 19,20 | +1,90% | 2,21% | 8.883.267 |